Novel Role of the SIRT1 in Endocrine and Metabolic Diseases

Silent information regulator 1 (SIRT1), a highly conserved NAD -dependent deacetylase, is a cellular regulator that has received extensive attention in recent years and regarded as a sensor of cellular energy and metabolism. The accumulated evidence suggests that SIRT1 is involved in the development...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of biological sciences Ročník 19; číslo 2; s. 484 - 501
Hlavní autoři:	Lu, Chenxi, Zhao, Huadong, Liu, Yanqing, Yang, Zhi, Yao, Hairong, Liu, Tong, Gou, Tiantian, Wang, Li, Zhang, Juan, Tian, Ye, Yang, Yang, Zhang, Huan
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Australia Ivyspring International Publisher Pty Ltd 2023 Ivyspring International Publisher
Témata:	Adipocytes Aging Apoptosis Autophagy Biomarkers Biomarkers - metabolism Deacetylation Diabetes Diabetes mellitus Endocrine system Endocrine System Diseases - diagnosis Endocrine System Diseases - drug therapy Endocrine System Diseases - metabolism Energy metabolism Female reproductive system Gene expression Glucose Histones Humans Hyperlipidemia Hypertension Hyperuricemia Insulin Kinases Lipids Localization Lysine Mammals Melatonin Metabolic Diseases - diagnosis Metabolic Diseases - drug therapy Metabolic Diseases - metabolism Metabolic disorders Molecular Targeted Therapy Osteoporosis Oxidative stress Pancreas Physiology Polycystic ovary syndrome Proteins Review Senescence SIRT1 protein Sirtuin 1 - metabolism Therapeutic targets Transcription factors Transcription Factors - metabolism inhibitors agonists SIRT1 endocrine metabolic
ISSN:	1449-2288, 1449-2288
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	Silent information regulator 1 (SIRT1), a highly conserved NAD -dependent deacetylase, is a cellular regulator that has received extensive attention in recent years and regarded as a sensor of cellular energy and metabolism. The accumulated evidence suggests that SIRT1 is involved in the development of endocrine and metabolic diseases. In a variety of organisms, SIRT1 regulates gene expression through the deacetylation of histone, transcription factors, and lysine residues of other modified proteins including several metabolic and endocrine signal transcription factors, thereby enhancing the therapeutic effects of endocrine and metabolic diseases. These evidences indicate that targeting SIRT1 has promising applications in the treatment of endocrine and metabolic diseases. This review focuses on the role of SIRT1 in endocrine and metabolic diseases. First, we describe the background and structure of SIRT1. Then, we outline the role of SIRT1 in endocrine and metabolic diseases such as hyperuricemia, diabetes, hypertension, hyperlipidemia, osteoporosis, and polycystic ovarian syndrome. Subsequently, the SIRT1 agonists and inhibitors in the above diseases are summarized and future research directions are proposed. Overall, the information presents here may highlight the potential of SIRT1 as a future biomarker and therapeutic target for endocrine and metabolic diseases.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 These authors contributed equally to this work. Competing Interests: The authors have declared that no competing interest exists.
ISSN:	1449-2288 1449-2288
DOI:	10.7150/ijbs.78654